AI Science Tracker
EN

Machine-learning analysis links glycolysis-related genes to osteosarcoma metastasis and survival

Department of Orthopaedics, Dongguan Tungwah Hospital, Dongguan, Guangdong, China · 27 Oct 2022 · medicine

Discovery

Machine-learning analysis links glycolysis-related genes to osteosarcoma metastasis and survival

Source check: Source checked. Not independent scientific confirmation.

Finding: Public osteosarcoma expression cohorts yielded a glycolysis-related survival score, and machine-learning ranking prioritized a metastasis-associated candidate subsequently tested in cell assays. Risk-group associations were checked in two additional GEO cohorts; the clinical evidence is retrospective, and the cell results do not establish patient-level causality.

Technology: Random forest and support-vector-machine feature ranking prioritized candidate genes; Cox regression formed the survival score.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Random forest and support-vector-machine feature ranking prioritized candidate genes; Cox regression formed the survival score.
Test and result
The study reports a 13-gene survival score evaluated in TARGET and two GEO cohorts; machine-learning ranking guided a cell-based follow-up of a metastasis-associated candidate.
Limitation / still unknown
The survival associations are retrospective; the cell assay does not establish patient-level causality or clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1047433/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.